Poop pills or scope: can donor stool tame ulcerative colitis?
NCT ID NCT07154784
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests fecal microbiota transplantation (FMT) in 30 people with mild-to-moderate ulcerative colitis. Participants receive donor stool either through a colonoscopy or as capsules at weeks 0 and 4. The goal is to see if FMT can help achieve steroid-free remission and improve symptoms over 48 weeks, while also checking for safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fecal microbiota transplantation (FMT) – donor stool given via colonoscopy or capsules
What this could lead to
If it works, this could offer a way to control ulcerative colitis without long-term steroids, possibly reducing flare-ups and improving quality of life.
What could go wrong
This is a small, early-phase study with only 30 participants. The treatment may not work for everyone, and there are risks of infection or worsening symptoms from the transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine
Seoul, Dongjak-gu, 07061, South Korea